Tant de raisons d’utiliser le kit CYTO dans vos projets
Le best seller des kits ScreenCell.
Parce que des chiffres valent mieux que des mots
Découvrez un éventail d'applications à votre disposition
Des résultats obtenus avec le kit CYTO
Nos notes d'application utilisant le kit CYTO
Explorez notre collection de notes d’application réalisées avec le kit CYTO, offrant des résultats uniques et enrichissants.
Cancer du poumon
Objectives Circulating tumour cells (CTCs) are reported to be predictive for prognosis and response to treatment in advanced lung cancer....
Adénocarcinome œsophagien
Introduction: Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently...
Cancer de la prostate
Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Cancer du sein
Background: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase...
Cancer du sein
Circulating tumor cells have a strong potential as a quasi-non-invasive tool for setting up a precision medicine strategy for cancer...
Cancer colorectal
Circulating tumor cells (CTCs) detach from a primary tumor or its metastases and circulate in the bloodstream. The vast majority...
Adénocarcinome œsophagien
Background/Aim: The presence of circulating tumor cells (CTC) has been reported to have an impact on prognosis in different tumor...
Cancer colorectal
Circulating tumour cells (CTC) were proven to be prognostically relevant in cancer treatment, e.g., in colorectal cancer (CRC). This study...
Cancer du sein
The isolation and analysis of circulating tumor cells (CTC) has the potential to provide minimally invasive diagnostic, prognostic and predictive...
Cancer du sein
Purpose The association between pathological complete response (pCR) in patients receiving neoadjuvant chemotherapy (NAC) for breast cancer and Circulating Tumour...
Cancer du poumon
Objectives Circulating tumour cells (CTCs) are reported to be predictive for prognosis and response to treatment in advanced lung cancer....
Adénocarcinome œsophagien
Introduction: Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently...
Cancer de la prostate
Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Cancer du sein
Background: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase...
Cancer du sein
Circulating tumor cells have a strong potential as a quasi-non-invasive tool for setting up a precision medicine strategy for cancer...
Cancer colorectal
Circulating tumor cells (CTCs) detach from a primary tumor or its metastases and circulate in the bloodstream. The vast majority...
Adénocarcinome œsophagien
Background/Aim: The presence of circulating tumor cells (CTC) has been reported to have an impact on prognosis in different tumor...
Cancer colorectal
Circulating tumour cells (CTC) were proven to be prognostically relevant in cancer treatment, e.g., in colorectal cancer (CRC). This study...
Cancer du sein
The isolation and analysis of circulating tumor cells (CTC) has the potential to provide minimally invasive diagnostic, prognostic and predictive...
Cancer du sein
Purpose The association between pathological complete response (pCR) in patients receiving neoadjuvant chemotherapy (NAC) for breast cancer and Circulating Tumour...
Les écrits restent,
les paroles s'envolent
Imprégnez-vous des articles scientifiques rédigés par nos clients et partenaires, qui ont utilisé le kit CYTO dans leurs recherches et témoignent de son efficacité.
Cancer du poumon
Objectives Circulating tumour cells (CTCs) are reported to be predictive for prognosis and response to treatment in advanced lung cancer....
Adénocarcinome œsophagien
Introduction: Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently...
Cancer de la prostate
Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Cancer du sein
Background: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase...
Cancer du poumon
Objectives Circulating tumour cells (CTCs) are reported to be predictive for prognosis and response to treatment in advanced lung cancer....
Adénocarcinome œsophagien
Introduction: Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently...
Cancer de la prostate
Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Cancer du sein
Background: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase...
Cancer du sein
Circulating tumor cells have a strong potential as a quasi-non-invasive tool for setting up a precision medicine strategy for cancer...
Cancer colorectal
Circulating tumor cells (CTCs) detach from a primary tumor or its metastases and circulate in the bloodstream. The vast majority...
Pour l'amélioration de la
prise en charge des patients
grâce à l'analyse des CTC
prise en charge des patients
grâce à l'analyse des CTC